MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, LPTX has $11,399K in assets. $8,704K in debts. $9,686K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
120.61%
Quick Ratio
120.61%
Cash Ratio
111.28%
Debt to Asset Ratio
76.36%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Deposits
    • Research and development incenti...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
9,686 18,130
Research and development incentive receivable
743 739
Prepaid expenses and other current assets
69 292
Total current assets
10,498 19,161
Right of use assets, net
38 38
Deferred costs
80 -
Deposits
783 784
Research and development incentive receivable, net of current portion
-59
Total assets
11,399 20,042
Accounts payable
4,279 7,339
Accrued expenses
3,860 6,623
Income tax payable
527 324
Lease liability
38 39
Total current liabilities
8,704 14,325
Total liabilities
8,704 -
Common stock, 0.001 par value 240,000,000 shares authorized 41,439,529 and 38,329,894 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
41 41
Additional paid-in capital
505,510 505,207
Accumulated other comprehensive loss
-104 -82
Accumulated deficit
-502,752 -499,449
Total stockholders' equity
2,695 5,717
Total liabilities and stockholders' equity
11,399 20,042
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$9,686K Research and developmentincentive receivable$743K Prepaid expenses andother current assets$69K Total current assets$10,498K Deposits$783K Deferred costs$80K Right of use assets,net$38K Total assets$11,399K Total liabilities andstockholders' equity$11,399K Total liabilities$8,704K Total stockholders'equity$2,695K Accumulated deficit-$502,752K Accumulated othercomprehensive loss-$104K Total currentliabilities$8,704K Additional paid-in capital$505,510K Common stock, 0.001 parvalue 240,000,000...$41K Accounts payable$4,279K Accrued expenses$3,860K Income tax payable$527K Lease liability$38K

LEAP THERAPEUTICS, INC. (LPTX)

LEAP THERAPEUTICS, INC. (LPTX)